Weight Loss with Pompe Disease in South Africa

Managing Glycogen Storage Disease Type II — Muscle, Metabolism & Safe Weight Control

By the WeightLossDiets.co.za Team | Updated June 2026

Pompe disease — also called glycogen storage disease type II (GSD II) or acid maltase deficiency — is a rare inherited metabolic disorder caused by mutations in the GAA gene. Without sufficient acid alpha-glucosidase (GAA) enzyme, glycogen accumulates in the lysosomes of muscle cells, progressively weakening skeletal and respiratory muscles. While most people associate Pompe disease with the severe infantile form, late-onset Pompe disease (LOPD) affects teenagers and adults and is increasingly diagnosed in South Africa through newborn screening and growing metabolic awareness.

For adults living with LOPD, weight management is a genuine and complex challenge. Reduced mobility, respiratory compromise, and the demands of enzyme replacement therapy (ERT) intersect in ways that make standard diet advice unhelpful — and sometimes harmful. This guide is written specifically for South Africans with Pompe disease, their carers, and the health professionals supporting them.

Why Weight Management Is Complicated in Pompe Disease

Pompe disease creates competing pressures that most diet programmes never account for:

• Progressive muscle loss: Glycogen accumulation destroys muscle fibres. As muscle mass declines, your basal metabolic rate drops — you burn fewer calories at rest. Standard calorie targets become inaccurate.
• Reduced activity tolerance: Proximal muscle weakness (hips, thighs, shoulders) and respiratory insufficiency mean that conventional exercise burns fewer calories than expected — and carries risk if pushed too hard.
• Ventilator dependence: Many LOPD patients eventually require nocturnal BiPAP or full-time ventilatory support, further restricting activity options.
• ERT logistics: Alglucosidase alfa (Myozyme) or newer avalglucosidase alfa (Nexviazyme) infusions are given every two weeks and take 4–5 hours. Travel to infusion centres — mainly at academic hospitals in Johannesburg, Cape Town, and Durban — is exhausting and disrupts eating patterns.
• BMI is unreliable: As muscle wastes and fat redistributes, a "normal" BMI can mask significant metabolic risk. Focus on functional capacity and waist circumference rather than the scale.

Dietary Principles for Pompe Disease

South African research and international Pompe guidelines converge on one nutritional priority: preserve muscle and avoid glycogen overload. Here is how that translates to practical eating:

1. High Protein — Non-Negotiable

Protein intake of 1.5–2.0 g per kilogram of body weight per day is recommended for LOPD adults. Protein supports muscle protein synthesis, which partially counteracts ongoing lysosomal muscle destruction and may improve ERT response. Good South African sources include:

• Lean biltong — high protein, portable, no refrigeration needed
• Eggs — complete amino acid profile, easy to prepare
• Chicken, fish, lean beef
• Full-cream plain yoghurt (Greek-style)
• Legumes (lentils, chickpeas) paired with grains for complete protein
• Whey or plant-based protein supplements if appetite is poor

2. Low-to-Moderate Carbohydrate

There is emerging evidence that reducing carbohydrate intake — particularly refined carbohydrates — may improve ERT efficacy by limiting the glycogen "load" arriving at lysosomes. A moderate approach works best:

• Replace white bread, white rice, and chips with sweet potato, legumes, oats, and whole grains
• Limit sugary drinks, sweets, and ultra-processed snacks
• Do not adopt strict keto (<20 g carbs/day) without specialist metabolic supervision — extreme carbohydrate restriction can be problematic in muscle disease

3. No Prolonged Fasting

Fasting triggers gluconeogenesis and can accelerate muscle protein breakdown in individuals with already compromised muscle mass. Eat every 3–4 hours and include a protein-containing snack before bed. This is especially important on ERT infusion days when fatigue is high and appetite may be suppressed.

4. Anti-Inflammatory Eating

Chronic inflammation accelerates muscle pathology. A Mediterranean-style approach — olive oil, fatty fish, colourful vegetables, rooibos tea, limited processed meat — supports both metabolic and cardiovascular health. Rooibos is naturally caffeine-free and rich in antioxidants; an excellent everyday drink for Pompe patients who need to limit stimulants that increase heart rate and oxygen demand.

5. Manage Dysphagia Early

As Pompe disease progresses, swallowing muscles weaken. Signs of dysphagia — coughing on fluids, food sticking, prolonged mealtimes — should trigger an immediate referral to a speech-language therapist. Modified texture diets and thickened fluids can prevent aspiration pneumonia, a potentially life-threatening complication.

Exercise with Pompe Disease — Possible and Beneficial

• Physiotherapy assessment first: A physiotherapist experienced in neuromuscular disease — available at most SA academic hospital neuromuscular clinics — should evaluate you before any programme begins
• Aquatic exercise: Hydrotherapy or pool walking reduces gravitational load on weakened hip and shoulder muscles and is one of the best-tolerated modalities for LOPD
• Low-impact strength training: Resistance bands, seated exercises, and light free weights can slow functional decline associated with disuse atrophy
• Respiratory muscle training: Inspiratory threshold devices help maintain breathing capacity and may delay ventilator dependence
• Avoid Valsalva manoeuvres: Heavy compound lifts, intense isometrics, and anything requiring breath-holding can dangerously compromise respiratory function
• Monitor oxygen saturation: A pulse oximeter (available at Dis-Chem or Clicks for around R300–R500) lets you check SpO2 during exercise. Stop if it drops below 94%.

ERT and Weight — What to Expect

Medical aid schemes are required to cover ERT under prescribed minimum benefits (PMB) for confirmed Pompe disease in South Africa. Important weight-related considerations:

• ERT infusion reactions may be managed with corticosteroid pre-medications. Repeated steroid exposure can cause weight gain, fluid retention, and blood sugar elevations. Discuss steroid stewardship — using the minimum effective pre-medication — with your metabolic team.
• After starting ERT, some patients experience improved respiratory function and activity tolerance, which over time supports more active weight management. Track function (6-minute walk distance, spirometry) rather than weight alone.
• Newer avalglucosidase alfa (Nexviazyme) shows superior glycogen clearance vs. alglucosidase alfa — if you are on older ERT and not responding well, ask your doctor about switching.

Sample Day of Eating for LOPD

Adjust portions to your body weight target (1.5–2 g protein per kg). A registered dietitian can personalise this plan.

South African Resources

• Metabolic dietitian referral: Via your metabolic specialist at Charlotte Maxeke Johannesburg Academic Hospital, Groote Schuur Hospital, Tygerberg Hospital, or Red Cross Children's Hospital
• Medical aid PMBs: Pompe disease is a listed PMB condition — ERT and dietitian consultations should be covered by all registered medical schemes
• ADSA (Association for Dietetics in South Africa): adsa.org.za — find a registered dietitian near you
• Pompe South Africa Facebook community: Informal peer support for patients and families across SA

Key Takeaways

• Prioritise protein (1.5–2 g/kg/day) above all other dietary changes
• Reduce refined carbs — moderate low-GI carbs are appropriate; strict keto requires specialist oversight
• Eat every 3–4 hours; never skip meals, especially on infusion days
• Exercise is beneficial — get a physiotherapy assessment first and monitor SpO2
• BMI is not a reliable outcome measure — track function and waist circumference
• Minimise steroid pre-medications where clinically safe
• Rooibos tea, olive oil, fatty fish, and colourful vegetables are your dietary allies

Sources: Pompe Disease Consortium guidelines; van der Ploeg AT et al. (2010) NEJM randomised study of alglucosidase alfa; NORD Rare Disease Database — Pompe Disease; Sanofi Genzyme South Africa patient information; ADSA position on inherited metabolic disease nutrition.